Breast Cancer Epidemiology, Prevention, and Screening

Progress in Molecular Biology and Translational Science
Stella WintersNavkiran K Shokar

Abstract

Globally, breast cancer is both the most commonly occurring cancer and the commonest cause of cancer death among women. Available data suggest that incidence and mortality in high-resource countries has been declining whereas incidence and mortality in low-resource countries has been increasing. This pattern is likely to be due to changing risk factor profiles and differences in access to breast cancer early detection and treatment. Risk factors for breast cancer include increasing age, race, menarche history, breast characteristics, reproductive patterns, hormone use, alcohol use, tobacco use, diet, physical activity, and body habitus. Mutations in the BRCA 1 and BRCA 2 tumor suppressor genes are significantly associated with the development of breast and ovarian cancer by the age of 70. Survival depends on both stage and molecular subtype. As there are few signs and symptoms early on, early detection is an important strategy to improve outcomes. Major professional organizations in the United States and elsewhere recommend screening with mammography with appropriate follow up for an abnormal screening test, although they differ somewhat by recommended ages and frequency of screening. Studies suggest a 15%-40% mortality reducti...Continue Reading

Citations

Jul 31, 2018·The British Journal of Radiology·María Pilar Sánchez-Camacho González-CarratoVicente Martínez-Vizcaíno
Jul 25, 2019·Clinics·Jesus Paula CarvalhoFilomena Marino Carvalho
Feb 26, 2019·Industrial Health·Alfredo Copertaro, Massimo Bracci
Jun 20, 2019·Current Molecular Medicine·Ying WeiXinhan Zhao
Sep 25, 2019·Nature Reviews. Disease Primers·Nadia HarbeckFatima Cardoso
Apr 8, 2020·Experimental and Therapeutic Medicine·Jianfen YuanZhimei Wu
Aug 6, 2020·Drug and Chemical Toxicology·Mohd MugheesSaima Wajid
Mar 17, 2020·Frontiers in Oncology·Balu WuYongchang Wei
Nov 28, 2019·Plastic and Reconstructive Surgery. Global Open·Ankur KhajuriaAfshin Mosahebi
Jun 26, 2020·Cancer Management and Research·Xian Hu ZhangXin Yao Wu
May 2, 2019·Journal of Cellular Biochemistry·Negin AminZatollah Asemi
Jun 20, 2020·Nature Reviews. Clinical Oncology·Nora PashayanMartin Widschwendter
Jul 24, 2020·Cancer Cell International·Augustin Le NaourAdrien Rossary
Sep 27, 2018·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Hamid Bakhshi AliabadMehdi Mahmoodi
Aug 9, 2020·OncoTargets and Therapy·Zelin TianGaosong Wu
May 8, 2020·Journal of Clinical Pathology·Camilla Paulla de SouzaFlavia Gehrke
Dec 10, 2020·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Xia-Liang LuYan-Qing Li
Sep 17, 2019·Life Sciences·Sajjad Ahmadpour, Seyed Jalal Hosseinimehr
Oct 14, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Amal Kamal Abdel-AzizSaverio Minucci
Feb 13, 2021·Purinergic Signalling·Julia Beatrice de AraújoDébora Tavares de Resende E Silva
Oct 26, 2020·The Breast Journal·Corrine ZarwanSusan E Pories
Dec 4, 2020·International Journal of Molecular Sciences·Louisane EveNelly Etienne-Selloum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Mediterranean Journal of Hematology and Infectious Diseases
Caterina Giovanna ValentiniLivio Pagano
Journal of the American Dietetic Association
H W Lane, J T Carpenter
© 2022 Meta ULC. All rights reserved